J2357 HCPCS Level II Code: Injection, omalizumab, 5 mg
Medicare Coverage & Payment
- Medicare coverage: Carrier judgment (CMS coverage code C)
- Payment category: Drugs (pricing indicator 51)
- BETOS: O1E — Other drugs
- Last CMS action effective: January 1, 2005
Source: CMS HCPCS Level II release. Coverage codes indicate how Medicare treats the code, not whether a specific claim will be paid; payer policy and documentation still govern.
Official Registry Overview & Definition
Injection, omalizumab, 5 mg is a HCPCS Level II code (J2357). CMS assigns coverage code C — Carrier judgment. Short description: Omalizumab injection.
Nearest Codes in This Family
Official HCPCS Level II classifications closest to J2357 in its code family, with their registry titles.
- J2351 — Injection, ocrelizumab, 1 mg and hyaluronidase-ocsq
- J2353 — Injection, octreotide, depot form for intramuscular injection, 1 mg
- J2354 — Injection, octreotide, non-depot form for subcutaneous or intravenous injection, 25 mcg
- J2355 — Injection, oprelvekin, 5 mg
- J2356 — Injection, tezepelumab-ekko, 1 mg
- J2358 — Injection, olanzapine, long-acting, 1 mg
- J2359 — Injection, olanzapine, 0.5 mg
- J2360 — Injection, orphenadrine citrate, up to 60 mg
- J2361 — Injection, depemokimab-ulaa, 1 mg
- J2370 — Injection, phenylephrine hcl, up to 1 ml